Targeting breast cancer stem cells by a self-assembled, aptamer-conjugated DNA nanotrain with preloading doxorubicin
Zhiyuan Xu,1 Ronghua Ni,1 Yun Chen1,21School of Pharmacy, Nanjing Medical University, Nanjing 211166, People’s Republic of China; 2State Key Laboratory of Reproductive Medicine, Nanjing 210029, People’s Republic of ChinaCorrespondence: Yun ChenSchool of Pharmacy, Nanjing Medical...
Guardado en:
Autores principales: | Xu Z, Ni R, Chen Y |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9b7e21103242479c8ff792d889d18abf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Design and clinical developments of aptamer-drug conjugates for targeted cancer therapy
por: Do-Hun Kim, et al.
Publicado: (2021) -
Aptamer–drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity
por: Dou XQ, et al.
Publicado: (2018) -
Targeted Therapy of Colon Cancer by Aptamer-Guided Holliday Junctions Loaded with Doxorubicin
por: Yao F, et al.
Publicado: (2020) -
Aptamer-Conjugated Quantum Dot Optical Biosensors: Strategies and Applications
por: Dongmin Kim, et al.
Publicado: (2021) -
Nucleic Acid-Based Treatments Against COVID-19: Potential Efficacy of Aptamers and siRNAs
por: Javad Khanali, et al.
Publicado: (2021)